United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
309.72
+8.33 (2.76%)
At close: Aug 13, 2025, 4:00 PM
308.73
-0.99 (-0.32%)
After-hours: Aug 13, 2025, 7:43 PM EDT
United Therapeutics Market Cap
United Therapeutics has a market cap or net worth of $14.01 billion as of August 13, 2025. Its market cap has decreased by -6.63% in one year.
Market Cap
14.01B
Enterprise Value
9.04B
1-Year Change
-6.63%
Ranking
Category
Stock Price
$309.72
Market Cap Chart
Since June 17, 1999, United Therapeutics's market cap has increased from $185.60M to $14.01B, an increase of 7,447.13%. That is a compound annual growth rate of 17.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 13.63B | -13.47% |
| Dec 31, 2024 | 15.75B | 52.44% |
| Dec 29, 2023 | 10.33B | -18.47% |
| Dec 30, 2022 | 12.67B | 30.24% |
| Dec 31, 2021 | 9.73B | 44.26% |
| Dec 31, 2020 | 6.75B | 74.53% |
| Dec 31, 2019 | 3.87B | -18.57% |
| Dec 31, 2018 | 4.75B | -25.75% |
| Dec 29, 2017 | 6.39B | 5.09% |
| Dec 30, 2016 | 6.08B | -14.87% |
| Dec 31, 2015 | 7.15B | 16.16% |
| Dec 31, 2014 | 6.15B | 8.32% |
| Dec 31, 2013 | 5.68B | 109.29% |
| Dec 31, 2012 | 2.71B | -1.54% |
| Dec 30, 2011 | 2.76B | -23.40% |
| Dec 31, 2010 | 3.60B | 26.94% |
| Dec 31, 2009 | 2.83B | 95.09% |
| Dec 31, 2008 | 1.45B | -30.01% |
| Dec 31, 2007 | 2.08B | 64.45% |
| Dec 29, 2006 | 1.26B | -20.99% |
| Dec 30, 2005 | 1.60B | 58.72% |
| Dec 31, 2004 | 1.01B | 105.98% |
| Dec 31, 2003 | 488.70M | 39.91% |
| Dec 31, 2002 | 349.30M | 65.94% |
| Dec 31, 2001 | 210.50M | -29.29% |
View and export this data all the way back to 1999.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 586.22B |
| Johnson & Johnson | 418.21B |
| AbbVie | 355.04B |
| UnitedHealth Group | 244.93B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 224.90B |
| Novo Nordisk | 223.00B |